netFormulary
 Report : A-Z HCD items in Formulary 17/06/2021 22:41:20
[Back]
 
Section Status Black Triangle Name
10.01.03 Formulary Black Triangle Adalimumab 
13.05.01 Formulary Black Triangle Alitretinoin 
10.01.03 Formulary Black Triangle Apremilast rheumatology
10.02 Formulary Black Triangle Ataluren 
10.04 Formulary Black Triangle Ataluren 
09.01.04 Formulary Black Triangle Avatrombopag 
10.01.03 Formulary Black Triangle Baricitinib 
13.05.03 Formulary Black Triangle Baricitinib Olumiant
02.12 Formulary Black Triangle Bempedoic acid nilemdo
13.05.03 Formulary Black Triangle Brodalumab Dermatology
11.08.02 Formulary Black Triangle Brolucizumab Beovu
04.07.04.02 Formulary Black Triangle Erenumab Aimovig
06.01.02.03 Formulary Black Triangle Ertugliflozin 
10.01.03 Formulary Black Triangle Filgotinib  Jyseleca
04.07.04.02 Formulary Black Triangle Fremanezumab Ajovy
04.07.04.02 Formulary Black Triangle Galcanezumab Emgality
08.01.05 Formulary Black Triangle Gilteritinib 
13.05.03 Formulary Black Triangle Guselkumab dermatology
08.02 Formulary Black Triangle Isatuximab Sarclisa
13.05.03 Formulary Black Triangle Ixekizumab dermatology
01.06.07 Formulary Black Triangle Linaclotide 
09.01.04 Formulary Black Triangle Lusutrombopag 
01.06.06 Formulary Black Triangle Naloxegol 
09.02.01.01 Formulary Black Triangle Patiromer Sorbitex Calcium Veltassa
14.04 Formulary Black Triangle Quadrivalent Influenza Vaccine  Split Virion, inactivated
13.05.03 Formulary Black Triangle Risankizumab Dermatology
10.01.03 Formulary Black Triangle Rituximab (rheumatology) 
10.01.03 Formulary Black Triangle Sarilumab 
10.01.03 Formulary Black Triangle Secukinumab Rheumatology
06.01.02.03 Formulary Black Triangle Semaglutide 
06.01.02.03 Formulary Black Triangle Semaglutide Rybelsus
04.08.01 Formulary Black Triangle Sodium Valproate Epilim Intravenous
04.08.01 Formulary Black Triangle Sodium Valproate 
04.08.01 Formulary Black Triangle Sodium Valproate Epilim Chrono
09.02.01.01 Formulary Black Triangle Sodium Zirconium Cyclosilicate Lokelma
09.01.05 Formulary Black Triangle Susoctocog alfa Obizur
13.05.03 Formulary Black Triangle Tildrakizumab Dermatology
01.05.03 Formulary Black Triangle Tofacitinib Gastroenterology
10.01.03 Formulary Black Triangle Tofacitinib citrate 
08.01.05 Formulary Black Triangle Trastuzumab deruxtecan Enhertu
06.07.02 Non Formulary Black Triangle Ulipristal Esmya
10.01.03 Formulary Black Triangle Upadacitinib 
04.02.03 Formulary Black Triangle Valproic Acid semisodium valproate
01.05.03 Formulary Black Triangle Vedolizumab 
Shropshire and Telford Local Health Economy